Previous Close | 0.0050 |
Open | 0.0050 |
Bid | 0.0050 x N/A |
Ask | 0.0100 x N/A |
Day's Range | 0.0050 - 0.0050 |
52 Week Range | 0.0050 - 0.0450 |
Volume | |
Avg. Volume | 526,291 |
Market Cap | 2.813M |
Beta (5Y Monthly) | 0.78 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0400 |
Earnings Date | Apr 30, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Continued focus on high-quality products and operational efficiencies drive bottom line improvementsTORONTO, April 29, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough companies that transform human wellness, today reported its financial results for the three months ended February 29, 2024 (“Q1 2024”) compared to the same per
TORONTO, April 15, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough ventures that transform human wellness, today announced that its subsidiary CannMart Inc. (“CannMart”) has made a landmark shipment of premium cannabis products to Australia, including vape carts plus two extracts from its own Roilty brand. In December 2023 C
TORONTO, April 03, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough ventures that transform human wellness, today announced that it has commenced restructuring proceedings pursuant to the Bankruptcy and Insolvency Act for one of its wholly owned subsidiaries, CannMart Labs Inc. (”CannMart Labs”). The restructuring of CannMart